| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 7554 |
| 1 | DEXAMETHASONE 1.5 MG | 6742 |
| 2 | CYCLOPHOSPHAMIDE | 6519 |
| 3 | LENALIDOMIDE | 5480 |
| 4 | CLOZAPINE | 4946 |
| 5 | RITUXIMAB | 4904 |
| 6 | METHOTREXATE SODIUM | 4138 |
| 7 | PALBOCICLIB | 4134 |
| 8 | CARBOPLATIN | 4076 |
| 9 | PREDNISONE | 4012 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERIBULIN MESYLATE | 441 | 0.1662 |
| 1 | DEXRAZOXANE FOR INJECTION | 79 | 0.1626 |
| 2 | DEXRAZOXANE HYDROCHLORIDE | 87 | 0.1620 |
| 3 | RIBOCICLIB | 1324 | 0.1417 |
| 4 | RHO (D) IMMUNE GLOBULIN | 41 | 0.1262 |
| 5 | TRABECTEDIN | 174 | 0.1099 |
| 6 | CEFTAROLINE FOSAMIL | 47 | 0.1056 |
| 7 | VINORELBINE | 507 | 0.1032 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 232 | 0.1005 |
| 9 | POLATUZUMAB VEDOTIN | 122 | 0.0999 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 14680 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 10240 |
| 2 | Platinum-based Drug [EPC] | 9632 |
| 3 | Alkylating Drug [EPC] | 9360 |
| 4 | Thalidomide Analog [EPC] | 7004 |
| 5 | Kinase Inhibitor [EPC] | 6863 |
| 6 | Atypical Antipsychotic [EPC] | 6503 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 5598 |
| 8 | Microtubule Inhibitor [EPC] | 5189 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5082 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 41 | 0.0949 |
| 1 | Topoisomerase Inhibitor [EPC] | 3287 | 0.0742 |
| 2 | Estrogen Receptor Antagonist [EPC] | 1204 | 0.0677 |
| 3 | Platinum-based Drug [EPC] | 9632 | 0.0626 |
| 4 | Recombinant Antithrombin [EPC] | 1 | 0.0625 |
| 5 | Alkylating Drug [EPC] | 9360 | 0.0603 |
| 6 | CD30-directed Immunoconjugate [EPC] | 307 | 0.0588 |
| 7 | CD33-directed Immunoconjugate [EPC] | 158 | 0.0576 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 10240 | 0.0556 |
| 9 | Microtubule Inhibitor [EPC] | 5189 | 0.0534 |